BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T100000
DTEND;TZID=America/Vancouver:20200513T110000
DTSTAMP:20260407T213857
CREATED:20200508T154133Z
LAST-MODIFIED:20200508T154133Z
UID:11302-1589364000-1589367600@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Jim Woodgett
DESCRIPTION:In this installment of the Stem Cells from the Sofa speaker series Dr. Jim Woodgett\, Director of Research at the Lunenfeld-Tanenbaum Research Institute\, will discuss the reopening of labs after the COVID-19 restrictions are eased. \nResearch has largely been shut down since the middle of March but there are increasing signs not only of buds on trees but plans for restoration of research activities. This needs to be carefully planned and depends on a number of factors that aren’t necessarily obvious. What are labs and research institutes doing to restore sanity in our pets and what can I do to help? Jim will discuss the processes the Lunenfeld-Tanenbaum Research Institute is going through\, the conditions and why the return environment will not be the same as when we left it seemingly 10 years ago. \nJim’s talk is entitled: “My dog wants to know when I can expect to return to my real day job in research”.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-jim-woodgett/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T100000
DTEND;TZID=America/Vancouver:20200513T110000
DTSTAMP:20260407T213857
CREATED:20200508T154133Z
LAST-MODIFIED:20200508T154133Z
UID:26158-1589364000-1589367600@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Jim Woodgett
DESCRIPTION:In this installment of the Stem Cells from the Sofa speaker series Dr. Jim Woodgett\, Director of Research at the Lunenfeld-Tanenbaum Research Institute\, will discuss the reopening of labs after the COVID-19 restrictions are eased. \nResearch has largely been shut down since the middle of March but there are increasing signs not only of buds on trees but plans for restoration of research activities. This needs to be carefully planned and depends on a number of factors that aren’t necessarily obvious. What are labs and research institutes doing to restore sanity in our pets and what can I do to help? Jim will discuss the processes the Lunenfeld-Tanenbaum Research Institute is going through\, the conditions and why the return environment will not be the same as when we left it seemingly 10 years ago. \nJim’s talk is entitled: “My dog wants to know when I can expect to return to my real day job in research”.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-jim-woodgett-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T100000
DTEND;TZID=America/Vancouver:20200513T110000
DTSTAMP:20260407T213857
CREATED:20200508T154133Z
LAST-MODIFIED:20200508T154133Z
UID:27773-1589364000-1589367600@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Jim Woodgett
DESCRIPTION:In this installment of the Stem Cells from the Sofa speaker series Dr. Jim Woodgett\, Director of Research at the Lunenfeld-Tanenbaum Research Institute\, will discuss the reopening of labs after the COVID-19 restrictions are eased. \nResearch has largely been shut down since the middle of March but there are increasing signs not only of buds on trees but plans for restoration of research activities. This needs to be carefully planned and depends on a number of factors that aren’t necessarily obvious. What are labs and research institutes doing to restore sanity in our pets and what can I do to help? Jim will discuss the processes the Lunenfeld-Tanenbaum Research Institute is going through\, the conditions and why the return environment will not be the same as when we left it seemingly 10 years ago. \nJim’s talk is entitled: “My dog wants to know when I can expect to return to my real day job in research”.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-jim-woodgett-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T100000
DTEND;TZID=America/Vancouver:20200513T110000
DTSTAMP:20260407T213857
CREATED:20200508T154133Z
LAST-MODIFIED:20200508T154133Z
UID:30856-1589364000-1589367600@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Jim Woodgett
DESCRIPTION:In this installment of the Stem Cells from the Sofa speaker series Dr. Jim Woodgett\, Director of Research at the Lunenfeld-Tanenbaum Research Institute\, will discuss the reopening of labs after the COVID-19 restrictions are eased. \nResearch has largely been shut down since the middle of March but there are increasing signs not only of buds on trees but plans for restoration of research activities. This needs to be carefully planned and depends on a number of factors that aren’t necessarily obvious. What are labs and research institutes doing to restore sanity in our pets and what can I do to help? Jim will discuss the processes the Lunenfeld-Tanenbaum Research Institute is going through\, the conditions and why the return environment will not be the same as when we left it seemingly 10 years ago. \nJim’s talk is entitled: “My dog wants to know when I can expect to return to my real day job in research”.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-jim-woodgett-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T100000
DTEND;TZID=America/Vancouver:20200513T110000
DTSTAMP:20260407T213857
CREATED:20200508T154133Z
LAST-MODIFIED:20200508T154133Z
UID:32316-1589364000-1589367600@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Jim Woodgett
DESCRIPTION:In this installment of the Stem Cells from the Sofa speaker series Dr. Jim Woodgett\, Director of Research at the Lunenfeld-Tanenbaum Research Institute\, will discuss the reopening of labs after the COVID-19 restrictions are eased. \nResearch has largely been shut down since the middle of March but there are increasing signs not only of buds on trees but plans for restoration of research activities. This needs to be carefully planned and depends on a number of factors that aren’t necessarily obvious. What are labs and research institutes doing to restore sanity in our pets and what can I do to help? Jim will discuss the processes the Lunenfeld-Tanenbaum Research Institute is going through\, the conditions and why the return environment will not be the same as when we left it seemingly 10 years ago. \nJim’s talk is entitled: “My dog wants to know when I can expect to return to my real day job in research”.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-jim-woodgett-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260407T213857
CREATED:20200421T225648Z
LAST-MODIFIED:20200421T225648Z
UID:11176-1589371200-1589374800@scienceinvancouver.com
SUMMARY:BCREGMED Quarantine Sessions
DESCRIPTION:CALLING ALL TRAINEES\n\n\n\n\nBC Regenerative Medicine is going digital and kicking off a reoccurring virtual seminar series organized and operated by trainees! \nEach seminar will give the trainee 20-25 minutes to present data relevant to their research followed by a 5-10 minute Q & A period. Seminars will be Wednesdays at 12pm and will happen so long as we have content!  \nMONTHLY CASH PRIZE for best seminar!!  \nDon’t have data ready to present but still want practice leading a seminar? Lead a Journal Club session instead!
URL:https://scienceinvancouver.com/event/bcregmed-quarantine-sessions-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/BCregmed-quarantine-seminars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260407T213857
CREATED:20200421T225648Z
LAST-MODIFIED:20200421T225648Z
UID:26151-1589371200-1589374800@scienceinvancouver.com
SUMMARY:BCREGMED Quarantine Sessions
DESCRIPTION:CALLING ALL TRAINEES\n\n\n\n\nBC Regenerative Medicine is going digital and kicking off a reoccurring virtual seminar series organized and operated by trainees! \nEach seminar will give the trainee 20-25 minutes to present data relevant to their research followed by a 5-10 minute Q & A period. Seminars will be Wednesdays at 12pm and will happen so long as we have content!  \nMONTHLY CASH PRIZE for best seminar!!  \nDon’t have data ready to present but still want practice leading a seminar? Lead a Journal Club session instead!
URL:https://scienceinvancouver.com/event/bcregmed-quarantine-sessions-3-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/BCregmed-quarantine-seminars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260407T213857
CREATED:20200421T225648Z
LAST-MODIFIED:20200421T225648Z
UID:27766-1589371200-1589374800@scienceinvancouver.com
SUMMARY:BCREGMED Quarantine Sessions
DESCRIPTION:CALLING ALL TRAINEES\n\n\n\n\nBC Regenerative Medicine is going digital and kicking off a reoccurring virtual seminar series organized and operated by trainees! \nEach seminar will give the trainee 20-25 minutes to present data relevant to their research followed by a 5-10 minute Q & A period. Seminars will be Wednesdays at 12pm and will happen so long as we have content!  \nMONTHLY CASH PRIZE for best seminar!!  \nDon’t have data ready to present but still want practice leading a seminar? Lead a Journal Club session instead!
URL:https://scienceinvancouver.com/event/bcregmed-quarantine-sessions-3-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/BCregmed-quarantine-seminars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260407T213857
CREATED:20200421T225648Z
LAST-MODIFIED:20200421T225648Z
UID:30849-1589371200-1589374800@scienceinvancouver.com
SUMMARY:BCREGMED Quarantine Sessions
DESCRIPTION:CALLING ALL TRAINEES\n\n\n\n\nBC Regenerative Medicine is going digital and kicking off a reoccurring virtual seminar series organized and operated by trainees! \nEach seminar will give the trainee 20-25 minutes to present data relevant to their research followed by a 5-10 minute Q & A period. Seminars will be Wednesdays at 12pm and will happen so long as we have content!  \nMONTHLY CASH PRIZE for best seminar!!  \nDon’t have data ready to present but still want practice leading a seminar? Lead a Journal Club session instead!
URL:https://scienceinvancouver.com/event/bcregmed-quarantine-sessions-3-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/BCregmed-quarantine-seminars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260407T213857
CREATED:20200421T225648Z
LAST-MODIFIED:20200421T225648Z
UID:32309-1589371200-1589374800@scienceinvancouver.com
SUMMARY:BCREGMED Quarantine Sessions
DESCRIPTION:CALLING ALL TRAINEES\n\n\n\n\nBC Regenerative Medicine is going digital and kicking off a reoccurring virtual seminar series organized and operated by trainees! \nEach seminar will give the trainee 20-25 minutes to present data relevant to their research followed by a 5-10 minute Q & A period. Seminars will be Wednesdays at 12pm and will happen so long as we have content!  \nMONTHLY CASH PRIZE for best seminar!!  \nDon’t have data ready to present but still want practice leading a seminar? Lead a Journal Club session instead!
URL:https://scienceinvancouver.com/event/bcregmed-quarantine-sessions-3-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/BCregmed-quarantine-seminars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200514T170000
DTEND;TZID=America/Vancouver:20200514T180000
DTSTAMP:20260407T213857
CREATED:20200505T214051Z
LAST-MODIFIED:20200505T214051Z
UID:11280-1589475600-1589479200@scienceinvancouver.com
SUMMARY:Responding to the COVID-19 Crisis: Rapid Viral Testing Developments
DESCRIPTION:The COVID-19 pandemic is an unprecedented global crisis.  One key problem has been the lack of test kits that can be used at home.  The existence of such test kits would make it far easier to understand and control this and future viral outbreaks.  However to date such a kit is not available. Dr. Unrau of SFU’s Department of Molecular Biology and Biochemistry will discuss why the development of such kits is not trivial and how the current pandemic might ultimately lead to the development of routine home viral testing. \n  \n*A Zoom link will be given to those who register*
URL:https://scienceinvancouver.com/event/responding-to-the-covid-19-crisis-rapid-viral-testing-developments/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/SFU-covid-talk.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200514T170000
DTEND;TZID=America/Vancouver:20200514T180000
DTSTAMP:20260407T213857
CREATED:20200505T214051Z
LAST-MODIFIED:20200505T214051Z
UID:26157-1589475600-1589479200@scienceinvancouver.com
SUMMARY:Responding to the COVID-19 Crisis: Rapid Viral Testing Developments
DESCRIPTION:The COVID-19 pandemic is an unprecedented global crisis.  One key problem has been the lack of test kits that can be used at home.  The existence of such test kits would make it far easier to understand and control this and future viral outbreaks.  However to date such a kit is not available. Dr. Unrau of SFU’s Department of Molecular Biology and Biochemistry will discuss why the development of such kits is not trivial and how the current pandemic might ultimately lead to the development of routine home viral testing. \n  \n*A Zoom link will be given to those who register*
URL:https://scienceinvancouver.com/event/responding-to-the-covid-19-crisis-rapid-viral-testing-developments-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/SFU-covid-talk.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200514T170000
DTEND;TZID=America/Vancouver:20200514T180000
DTSTAMP:20260407T213857
CREATED:20200505T214051Z
LAST-MODIFIED:20200505T214051Z
UID:27772-1589475600-1589479200@scienceinvancouver.com
SUMMARY:Responding to the COVID-19 Crisis: Rapid Viral Testing Developments
DESCRIPTION:The COVID-19 pandemic is an unprecedented global crisis.  One key problem has been the lack of test kits that can be used at home.  The existence of such test kits would make it far easier to understand and control this and future viral outbreaks.  However to date such a kit is not available. Dr. Unrau of SFU’s Department of Molecular Biology and Biochemistry will discuss why the development of such kits is not trivial and how the current pandemic might ultimately lead to the development of routine home viral testing. \n  \n*A Zoom link will be given to those who register*
URL:https://scienceinvancouver.com/event/responding-to-the-covid-19-crisis-rapid-viral-testing-developments-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/SFU-covid-talk.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200514T170000
DTEND;TZID=America/Vancouver:20200514T180000
DTSTAMP:20260407T213857
CREATED:20200505T214051Z
LAST-MODIFIED:20200505T214051Z
UID:30855-1589475600-1589479200@scienceinvancouver.com
SUMMARY:Responding to the COVID-19 Crisis: Rapid Viral Testing Developments
DESCRIPTION:The COVID-19 pandemic is an unprecedented global crisis.  One key problem has been the lack of test kits that can be used at home.  The existence of such test kits would make it far easier to understand and control this and future viral outbreaks.  However to date such a kit is not available. Dr. Unrau of SFU’s Department of Molecular Biology and Biochemistry will discuss why the development of such kits is not trivial and how the current pandemic might ultimately lead to the development of routine home viral testing. \n  \n*A Zoom link will be given to those who register*
URL:https://scienceinvancouver.com/event/responding-to-the-covid-19-crisis-rapid-viral-testing-developments-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/SFU-covid-talk.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200514T170000
DTEND;TZID=America/Vancouver:20200514T180000
DTSTAMP:20260407T213857
CREATED:20200505T214051Z
LAST-MODIFIED:20200505T214051Z
UID:32315-1589475600-1589479200@scienceinvancouver.com
SUMMARY:Responding to the COVID-19 Crisis: Rapid Viral Testing Developments
DESCRIPTION:The COVID-19 pandemic is an unprecedented global crisis.  One key problem has been the lack of test kits that can be used at home.  The existence of such test kits would make it far easier to understand and control this and future viral outbreaks.  However to date such a kit is not available. Dr. Unrau of SFU’s Department of Molecular Biology and Biochemistry will discuss why the development of such kits is not trivial and how the current pandemic might ultimately lead to the development of routine home viral testing. \n  \n*A Zoom link will be given to those who register*
URL:https://scienceinvancouver.com/event/responding-to-the-covid-19-crisis-rapid-viral-testing-developments-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/SFU-covid-talk.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T080000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T173531Z
LAST-MODIFIED:20200515T173638Z
UID:11360-1589961600-1589968800@scienceinvancouver.com
SUMMARY:COVID-19: The Road Forward Gairdner Global Perspectives Panel
DESCRIPTION:Join us for an exploration of the science of coronavirus infections\, the urgent search for new drug therapies and new vaccines\, how to model the time course of pandemic outbreaks and the social and economic impact on vulnerable populations worldwide. \nWe bring together illustrious Canada Gairdner laureates\, alongside an outstanding Canadian scientist and previous Chair of the Gairdner Board of Directors\, to provide their unique insights into the pandemic and the hope for the future. \nQuarraisha and Salim Abdool Karim \nQuarraisha and Salim Abdool Karim are the founding leaders of the Centre for the AIDS Program of Research in South Africa (CAPRISA)\, Professors at Columbia University\, and Pro-Vice Chancellors at University of KwaZulu-Natal\, Durban\, South Africa. They are the 2020 John Dirks Canada Gairdner Global Health Award laureates for their discovery that antiretrovirals prevent sexual transmission of HIV\, laying the foundations for pre-exposure prophylaxis (PrEP) and contributing to the reduction of HIV infection in Africa and around the world. Their scientific work has been amplified by their focus on the social and behavioral aspects of prevention\, transmission and treatment. \nMore information about Quarraisha and Salim Abdool Karim. \nD. Lorne Tyrrell \nLorne Tyrrell is the Founding Director\, Li Ka Shing Institute of Virology\, University of Alberta\, in Edmonton\, AB\, Canada and Chair Emeritus\, Gairdner Foundation. For four decades he has been a leading figure in Canadian health research and in understanding and addressing viral disease\, in particular hepatitis B and C. \nMore information about Lorne Tyrrell. \nChristopher Murray \nChristopher Murray is the Director of the Institute for Health Metrics and Evaluation (IHME)\, and Professor of Global Health\, University of Washington in Seattle\, WA\, USA. Along with longtime collaborator Alan Lopez\, he received the 2018 John Dirks Canada Gairdner Global Health Award for conceptualizing and quantifying the Global Burden of Disease\, part of an extensive career in understanding and interpreting the data of health worldwide. \nMore information about Christopher Murray. \nRino Rappuoli \nRino Rappuoli is Chief Scientist and Head External R&D\, GSK Vaccines in Siena\, Italy and 2017 Canada Gairdner International Award laureate for reverse vaccinology\, a genomic approach to vaccine discovery that resulted in a life-saving meningococcus B vaccine. Dr. Rappuoli is a leader in vaccine innovation\, introducing novel scientific concepts including genetic detoxification\, cellular microbiology\, reverse vaccinology\, and pangenome.
URL:https://scienceinvancouver.com/event/covid-19-the-road-forward-gairdner-global-perspectives-panel/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Gairdner-Global-Perspectives-Panel-May-20.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T080000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T173531Z
LAST-MODIFIED:20200515T173531Z
UID:26163-1589961600-1589968800@scienceinvancouver.com
SUMMARY:COVID-19: The Road Forward Gairdner Global Perspectives Panel
DESCRIPTION:Join us for an exploration of the science of coronavirus infections\, the urgent search for new drug therapies and new vaccines\, how to model the time course of pandemic outbreaks and the social and economic impact on vulnerable populations worldwide. \nWe bring together illustrious Canada Gairdner laureates\, alongside an outstanding Canadian scientist and previous Chair of the Gairdner Board of Directors\, to provide their unique insights into the pandemic and the hope for the future. \nQuarraisha and Salim Abdool Karim \nQuarraisha and Salim Abdool Karim are the founding leaders of the Centre for the AIDS Program of Research in South Africa (CAPRISA)\, Professors at Columbia University\, and Pro-Vice Chancellors at University of KwaZulu-Natal\, Durban\, South Africa. They are the 2020 John Dirks Canada Gairdner Global Health Award laureates for their discovery that antiretrovirals prevent sexual transmission of HIV\, laying the foundations for pre-exposure prophylaxis (PrEP) and contributing to the reduction of HIV infection in Africa and around the world. Their scientific work has been amplified by their focus on the social and behavioral aspects of prevention\, transmission and treatment. \nMore information about Quarraisha and Salim Abdool Karim. \nD. Lorne Tyrrell \nLorne Tyrrell is the Founding Director\, Li Ka Shing Institute of Virology\, University of Alberta\, in Edmonton\, AB\, Canada and Chair Emeritus\, Gairdner Foundation. For four decades he has been a leading figure in Canadian health research and in understanding and addressing viral disease\, in particular hepatitis B and C. \nMore information about Lorne Tyrrell. \nChristopher Murray \nChristopher Murray is the Director of the Institute for Health Metrics and Evaluation (IHME)\, and Professor of Global Health\, University of Washington in Seattle\, WA\, USA. Along with longtime collaborator Alan Lopez\, he received the 2018 John Dirks Canada Gairdner Global Health Award for conceptualizing and quantifying the Global Burden of Disease\, part of an extensive career in understanding and interpreting the data of health worldwide. \nMore information about Christopher Murray. \nRino Rappuoli \nRino Rappuoli is Chief Scientist and Head External R&D\, GSK Vaccines in Siena\, Italy and 2017 Canada Gairdner International Award laureate for reverse vaccinology\, a genomic approach to vaccine discovery that resulted in a life-saving meningococcus B vaccine. Dr. Rappuoli is a leader in vaccine innovation\, introducing novel scientific concepts including genetic detoxification\, cellular microbiology\, reverse vaccinology\, and pangenome.
URL:https://scienceinvancouver.com/event/covid-19-the-road-forward-gairdner-global-perspectives-panel-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Gairdner-Global-Perspectives-Panel-May-20.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T080000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T173531Z
LAST-MODIFIED:20200515T173531Z
UID:27778-1589961600-1589968800@scienceinvancouver.com
SUMMARY:COVID-19: The Road Forward Gairdner Global Perspectives Panel
DESCRIPTION:Join us for an exploration of the science of coronavirus infections\, the urgent search for new drug therapies and new vaccines\, how to model the time course of pandemic outbreaks and the social and economic impact on vulnerable populations worldwide. \nWe bring together illustrious Canada Gairdner laureates\, alongside an outstanding Canadian scientist and previous Chair of the Gairdner Board of Directors\, to provide their unique insights into the pandemic and the hope for the future. \nQuarraisha and Salim Abdool Karim \nQuarraisha and Salim Abdool Karim are the founding leaders of the Centre for the AIDS Program of Research in South Africa (CAPRISA)\, Professors at Columbia University\, and Pro-Vice Chancellors at University of KwaZulu-Natal\, Durban\, South Africa. They are the 2020 John Dirks Canada Gairdner Global Health Award laureates for their discovery that antiretrovirals prevent sexual transmission of HIV\, laying the foundations for pre-exposure prophylaxis (PrEP) and contributing to the reduction of HIV infection in Africa and around the world. Their scientific work has been amplified by their focus on the social and behavioral aspects of prevention\, transmission and treatment. \nMore information about Quarraisha and Salim Abdool Karim. \nD. Lorne Tyrrell \nLorne Tyrrell is the Founding Director\, Li Ka Shing Institute of Virology\, University of Alberta\, in Edmonton\, AB\, Canada and Chair Emeritus\, Gairdner Foundation. For four decades he has been a leading figure in Canadian health research and in understanding and addressing viral disease\, in particular hepatitis B and C. \nMore information about Lorne Tyrrell. \nChristopher Murray \nChristopher Murray is the Director of the Institute for Health Metrics and Evaluation (IHME)\, and Professor of Global Health\, University of Washington in Seattle\, WA\, USA. Along with longtime collaborator Alan Lopez\, he received the 2018 John Dirks Canada Gairdner Global Health Award for conceptualizing and quantifying the Global Burden of Disease\, part of an extensive career in understanding and interpreting the data of health worldwide. \nMore information about Christopher Murray. \nRino Rappuoli \nRino Rappuoli is Chief Scientist and Head External R&D\, GSK Vaccines in Siena\, Italy and 2017 Canada Gairdner International Award laureate for reverse vaccinology\, a genomic approach to vaccine discovery that resulted in a life-saving meningococcus B vaccine. Dr. Rappuoli is a leader in vaccine innovation\, introducing novel scientific concepts including genetic detoxification\, cellular microbiology\, reverse vaccinology\, and pangenome.
URL:https://scienceinvancouver.com/event/covid-19-the-road-forward-gairdner-global-perspectives-panel-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Gairdner-Global-Perspectives-Panel-May-20.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T080000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T173531Z
LAST-MODIFIED:20200515T173531Z
UID:30861-1589961600-1589968800@scienceinvancouver.com
SUMMARY:COVID-19: The Road Forward Gairdner Global Perspectives Panel
DESCRIPTION:Join us for an exploration of the science of coronavirus infections\, the urgent search for new drug therapies and new vaccines\, how to model the time course of pandemic outbreaks and the social and economic impact on vulnerable populations worldwide. \nWe bring together illustrious Canada Gairdner laureates\, alongside an outstanding Canadian scientist and previous Chair of the Gairdner Board of Directors\, to provide their unique insights into the pandemic and the hope for the future. \nQuarraisha and Salim Abdool Karim \nQuarraisha and Salim Abdool Karim are the founding leaders of the Centre for the AIDS Program of Research in South Africa (CAPRISA)\, Professors at Columbia University\, and Pro-Vice Chancellors at University of KwaZulu-Natal\, Durban\, South Africa. They are the 2020 John Dirks Canada Gairdner Global Health Award laureates for their discovery that antiretrovirals prevent sexual transmission of HIV\, laying the foundations for pre-exposure prophylaxis (PrEP) and contributing to the reduction of HIV infection in Africa and around the world. Their scientific work has been amplified by their focus on the social and behavioral aspects of prevention\, transmission and treatment. \nMore information about Quarraisha and Salim Abdool Karim. \nD. Lorne Tyrrell \nLorne Tyrrell is the Founding Director\, Li Ka Shing Institute of Virology\, University of Alberta\, in Edmonton\, AB\, Canada and Chair Emeritus\, Gairdner Foundation. For four decades he has been a leading figure in Canadian health research and in understanding and addressing viral disease\, in particular hepatitis B and C. \nMore information about Lorne Tyrrell. \nChristopher Murray \nChristopher Murray is the Director of the Institute for Health Metrics and Evaluation (IHME)\, and Professor of Global Health\, University of Washington in Seattle\, WA\, USA. Along with longtime collaborator Alan Lopez\, he received the 2018 John Dirks Canada Gairdner Global Health Award for conceptualizing and quantifying the Global Burden of Disease\, part of an extensive career in understanding and interpreting the data of health worldwide. \nMore information about Christopher Murray. \nRino Rappuoli \nRino Rappuoli is Chief Scientist and Head External R&D\, GSK Vaccines in Siena\, Italy and 2017 Canada Gairdner International Award laureate for reverse vaccinology\, a genomic approach to vaccine discovery that resulted in a life-saving meningococcus B vaccine. Dr. Rappuoli is a leader in vaccine innovation\, introducing novel scientific concepts including genetic detoxification\, cellular microbiology\, reverse vaccinology\, and pangenome.
URL:https://scienceinvancouver.com/event/covid-19-the-road-forward-gairdner-global-perspectives-panel-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Gairdner-Global-Perspectives-Panel-May-20.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T080000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T173531Z
LAST-MODIFIED:20200515T173531Z
UID:32321-1589961600-1589968800@scienceinvancouver.com
SUMMARY:COVID-19: The Road Forward Gairdner Global Perspectives Panel
DESCRIPTION:Join us for an exploration of the science of coronavirus infections\, the urgent search for new drug therapies and new vaccines\, how to model the time course of pandemic outbreaks and the social and economic impact on vulnerable populations worldwide. \nWe bring together illustrious Canada Gairdner laureates\, alongside an outstanding Canadian scientist and previous Chair of the Gairdner Board of Directors\, to provide their unique insights into the pandemic and the hope for the future. \nQuarraisha and Salim Abdool Karim \nQuarraisha and Salim Abdool Karim are the founding leaders of the Centre for the AIDS Program of Research in South Africa (CAPRISA)\, Professors at Columbia University\, and Pro-Vice Chancellors at University of KwaZulu-Natal\, Durban\, South Africa. They are the 2020 John Dirks Canada Gairdner Global Health Award laureates for their discovery that antiretrovirals prevent sexual transmission of HIV\, laying the foundations for pre-exposure prophylaxis (PrEP) and contributing to the reduction of HIV infection in Africa and around the world. Their scientific work has been amplified by their focus on the social and behavioral aspects of prevention\, transmission and treatment. \nMore information about Quarraisha and Salim Abdool Karim. \nD. Lorne Tyrrell \nLorne Tyrrell is the Founding Director\, Li Ka Shing Institute of Virology\, University of Alberta\, in Edmonton\, AB\, Canada and Chair Emeritus\, Gairdner Foundation. For four decades he has been a leading figure in Canadian health research and in understanding and addressing viral disease\, in particular hepatitis B and C. \nMore information about Lorne Tyrrell. \nChristopher Murray \nChristopher Murray is the Director of the Institute for Health Metrics and Evaluation (IHME)\, and Professor of Global Health\, University of Washington in Seattle\, WA\, USA. Along with longtime collaborator Alan Lopez\, he received the 2018 John Dirks Canada Gairdner Global Health Award for conceptualizing and quantifying the Global Burden of Disease\, part of an extensive career in understanding and interpreting the data of health worldwide. \nMore information about Christopher Murray. \nRino Rappuoli \nRino Rappuoli is Chief Scientist and Head External R&D\, GSK Vaccines in Siena\, Italy and 2017 Canada Gairdner International Award laureate for reverse vaccinology\, a genomic approach to vaccine discovery that resulted in a life-saving meningococcus B vaccine. Dr. Rappuoli is a leader in vaccine innovation\, introducing novel scientific concepts including genetic detoxification\, cellular microbiology\, reverse vaccinology\, and pangenome.
URL:https://scienceinvancouver.com/event/covid-19-the-road-forward-gairdner-global-perspectives-panel-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/Gairdner-Global-Perspectives-Panel-May-20.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T090000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T174318Z
LAST-MODIFIED:20200515T174318Z
UID:11369-1589965200-1589968800@scienceinvancouver.com
SUMMARY:Webinar: Microfluidic 3D Bioprinting and Functional Characterization of a Contractile Smooth Muscle Tissue Model
DESCRIPTION:Join us for the first installment of our webinar series\, in which Spiro Getsios\, PhD\, VP of Tissue Engineering at Aspect Biosystems\, will highlight: \n\nKey features and core concepts of our microfluidic 3D bioprinting platform\nBioink and design considerations for creating functional tissue\nHow these concepts have been applied in developing a bioprinted contractile smooth muscle model\n\n\n\n\n\nPRESENTER – SPIRO GETSIOS\, PHD\nVice President\, Tissue Engineering\n\nSpiro is the Vice President of Tissue Engineering at Aspect and manages all partnered and internal tissue engineering programs. Prior to joining Aspect\, Spiro served as Associate Professor of Dermatology and Director of Skin Tissue Engineering at Northwestern University and Director of Biology at GlaxoSmithKline\, focusing on delivering preclinical models for drug discovery and development. \n\n\n\n\n\n\n\n\n\nMODERATOR – ELLI KÄPYLÄ\, PHD\nManager of Academic Alliances & Applications Scientist\nElli received her PhD in Biomedical Engineering from Tampere University of Technology in Finland\, specializing in biomaterials and 3D printing. She joined Aspect as a Research Scientist in 2017\, where she focused on the development of biomaterials for 3D printed implantable tissues. Now back in Finland\, Elli supports our customers in her role as Manager of Academic Alliances & Applications Scientist.
URL:https://scienceinvancouver.com/event/webinar-microfluidic-3d-bioprinting-and-functional-characterization-of-a-contractile-smooth-muscle-tissue-model/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T090000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T174318Z
LAST-MODIFIED:20200515T174318Z
UID:26164-1589965200-1589968800@scienceinvancouver.com
SUMMARY:Webinar: Microfluidic 3D Bioprinting and Functional Characterization of a Contractile Smooth Muscle Tissue Model
DESCRIPTION:Join us for the first installment of our webinar series\, in which Spiro Getsios\, PhD\, VP of Tissue Engineering at Aspect Biosystems\, will highlight: \n\nKey features and core concepts of our microfluidic 3D bioprinting platform\nBioink and design considerations for creating functional tissue\nHow these concepts have been applied in developing a bioprinted contractile smooth muscle model\n\n\n\n\n\nPRESENTER – SPIRO GETSIOS\, PHD\nVice President\, Tissue Engineering\n\nSpiro is the Vice President of Tissue Engineering at Aspect and manages all partnered and internal tissue engineering programs. Prior to joining Aspect\, Spiro served as Associate Professor of Dermatology and Director of Skin Tissue Engineering at Northwestern University and Director of Biology at GlaxoSmithKline\, focusing on delivering preclinical models for drug discovery and development. \n\n\n\n\n\n\n\n\n\nMODERATOR – ELLI KÄPYLÄ\, PHD\nManager of Academic Alliances & Applications Scientist\nElli received her PhD in Biomedical Engineering from Tampere University of Technology in Finland\, specializing in biomaterials and 3D printing. She joined Aspect as a Research Scientist in 2017\, where she focused on the development of biomaterials for 3D printed implantable tissues. Now back in Finland\, Elli supports our customers in her role as Manager of Academic Alliances & Applications Scientist.
URL:https://scienceinvancouver.com/event/webinar-microfluidic-3d-bioprinting-and-functional-characterization-of-a-contractile-smooth-muscle-tissue-model-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T090000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T174318Z
LAST-MODIFIED:20200515T174318Z
UID:27779-1589965200-1589968800@scienceinvancouver.com
SUMMARY:Webinar: Microfluidic 3D Bioprinting and Functional Characterization of a Contractile Smooth Muscle Tissue Model
DESCRIPTION:Join us for the first installment of our webinar series\, in which Spiro Getsios\, PhD\, VP of Tissue Engineering at Aspect Biosystems\, will highlight: \n\nKey features and core concepts of our microfluidic 3D bioprinting platform\nBioink and design considerations for creating functional tissue\nHow these concepts have been applied in developing a bioprinted contractile smooth muscle model\n\n\n\n\n\nPRESENTER – SPIRO GETSIOS\, PHD\nVice President\, Tissue Engineering\n\nSpiro is the Vice President of Tissue Engineering at Aspect and manages all partnered and internal tissue engineering programs. Prior to joining Aspect\, Spiro served as Associate Professor of Dermatology and Director of Skin Tissue Engineering at Northwestern University and Director of Biology at GlaxoSmithKline\, focusing on delivering preclinical models for drug discovery and development. \n\n\n\n\n\n\n\n\n\nMODERATOR – ELLI KÄPYLÄ\, PHD\nManager of Academic Alliances & Applications Scientist\nElli received her PhD in Biomedical Engineering from Tampere University of Technology in Finland\, specializing in biomaterials and 3D printing. She joined Aspect as a Research Scientist in 2017\, where she focused on the development of biomaterials for 3D printed implantable tissues. Now back in Finland\, Elli supports our customers in her role as Manager of Academic Alliances & Applications Scientist.
URL:https://scienceinvancouver.com/event/webinar-microfluidic-3d-bioprinting-and-functional-characterization-of-a-contractile-smooth-muscle-tissue-model-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T090000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T174318Z
LAST-MODIFIED:20200515T174318Z
UID:30862-1589965200-1589968800@scienceinvancouver.com
SUMMARY:Webinar: Microfluidic 3D Bioprinting and Functional Characterization of a Contractile Smooth Muscle Tissue Model
DESCRIPTION:Join us for the first installment of our webinar series\, in which Spiro Getsios\, PhD\, VP of Tissue Engineering at Aspect Biosystems\, will highlight: \n\nKey features and core concepts of our microfluidic 3D bioprinting platform\nBioink and design considerations for creating functional tissue\nHow these concepts have been applied in developing a bioprinted contractile smooth muscle model\n\n\n\n\n\nPRESENTER – SPIRO GETSIOS\, PHD\nVice President\, Tissue Engineering\n\nSpiro is the Vice President of Tissue Engineering at Aspect and manages all partnered and internal tissue engineering programs. Prior to joining Aspect\, Spiro served as Associate Professor of Dermatology and Director of Skin Tissue Engineering at Northwestern University and Director of Biology at GlaxoSmithKline\, focusing on delivering preclinical models for drug discovery and development. \n\n\n\n\n\n\n\n\n\nMODERATOR – ELLI KÄPYLÄ\, PHD\nManager of Academic Alliances & Applications Scientist\nElli received her PhD in Biomedical Engineering from Tampere University of Technology in Finland\, specializing in biomaterials and 3D printing. She joined Aspect as a Research Scientist in 2017\, where she focused on the development of biomaterials for 3D printed implantable tissues. Now back in Finland\, Elli supports our customers in her role as Manager of Academic Alliances & Applications Scientist.
URL:https://scienceinvancouver.com/event/webinar-microfluidic-3d-bioprinting-and-functional-characterization-of-a-contractile-smooth-muscle-tissue-model-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T090000
DTEND;TZID=America/Vancouver:20200520T100000
DTSTAMP:20260407T213857
CREATED:20200515T174318Z
LAST-MODIFIED:20200515T174318Z
UID:32322-1589965200-1589968800@scienceinvancouver.com
SUMMARY:Webinar: Microfluidic 3D Bioprinting and Functional Characterization of a Contractile Smooth Muscle Tissue Model
DESCRIPTION:Join us for the first installment of our webinar series\, in which Spiro Getsios\, PhD\, VP of Tissue Engineering at Aspect Biosystems\, will highlight: \n\nKey features and core concepts of our microfluidic 3D bioprinting platform\nBioink and design considerations for creating functional tissue\nHow these concepts have been applied in developing a bioprinted contractile smooth muscle model\n\n\n\n\n\nPRESENTER – SPIRO GETSIOS\, PHD\nVice President\, Tissue Engineering\n\nSpiro is the Vice President of Tissue Engineering at Aspect and manages all partnered and internal tissue engineering programs. Prior to joining Aspect\, Spiro served as Associate Professor of Dermatology and Director of Skin Tissue Engineering at Northwestern University and Director of Biology at GlaxoSmithKline\, focusing on delivering preclinical models for drug discovery and development. \n\n\n\n\n\n\n\n\n\nMODERATOR – ELLI KÄPYLÄ\, PHD\nManager of Academic Alliances & Applications Scientist\nElli received her PhD in Biomedical Engineering from Tampere University of Technology in Finland\, specializing in biomaterials and 3D printing. She joined Aspect as a Research Scientist in 2017\, where she focused on the development of biomaterials for 3D printed implantable tissues. Now back in Finland\, Elli supports our customers in her role as Manager of Academic Alliances & Applications Scientist.
URL:https://scienceinvancouver.com/event/webinar-microfluidic-3d-bioprinting-and-functional-characterization-of-a-contractile-smooth-muscle-tissue-model-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T113000
DTEND;TZID=America/Vancouver:20200520T123000
DTSTAMP:20260407T213857
CREATED:20200514T195109Z
LAST-MODIFIED:20200514T195109Z
UID:11341-1589974200-1589977800@scienceinvancouver.com
SUMMARY:Webinar: Tackling COVID-19: Global Collaborations in Therapeutic Drug Trials and Vaccine Development
DESCRIPTION:It’s an unusual time in the world of medical and pharmaceutical research. The slow\, methodical work that is typically conducted out of view by researchers in labs around the world has been driven into the spotlight by a worldwide need for hope. The hope for effective treatments\, vaccines\, and a return to “normal” is coming from many different directions. The World Health Organization Solidarity Trial\, a multi-national collaboration\, is running clinical trials in an effort to determine which drugs are effective in treating the symptoms of COVID-19. At the same time\, work is also underway towards identifying potential vaccines. Join UBC experts from the Faculty of Medicine and Faculty of Pharmaceutical Sciences as they explain the process and timelines of developing and testing therapeutic drugs and vaccines for COVID-19\, and learn why a global approach is so important. \nThis is the fifth webinar in our COVID-19 series. View the previous webinars here. \nThis webinar is open to all. \nModerated by\nMary Lynn Young – Associate Professor\, UBC School of Journalism; Co-Founder\, The Conversation Canada \nFeaturing\nDr. Fawziah Lalji\, BSc’90\, PharmD’94 – Professor\, UBC Faculty of Pharmaceutical Sciences; Tong Louie Chair in Pharmaceutical Sciences \nDr. Srinivas Murthy\, MHSc’16 – Clinical Associate Professor\, UBC Department of Pediatrics; Infectious Disease Specialist and Investigator at BC Children’s Hospital
URL:https://scienceinvancouver.com/event/webinar-tackling-covid-19-global-collaborations-in-therapeutic-drug-trials-and-vaccine-development/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/COVID19-webinar-May-20.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T113000
DTEND;TZID=America/Vancouver:20200520T123000
DTSTAMP:20260407T213857
CREATED:20200514T195109Z
LAST-MODIFIED:20200514T195109Z
UID:26161-1589974200-1589977800@scienceinvancouver.com
SUMMARY:Webinar: Tackling COVID-19: Global Collaborations in Therapeutic Drug Trials and Vaccine Development
DESCRIPTION:It’s an unusual time in the world of medical and pharmaceutical research. The slow\, methodical work that is typically conducted out of view by researchers in labs around the world has been driven into the spotlight by a worldwide need for hope. The hope for effective treatments\, vaccines\, and a return to “normal” is coming from many different directions. The World Health Organization Solidarity Trial\, a multi-national collaboration\, is running clinical trials in an effort to determine which drugs are effective in treating the symptoms of COVID-19. At the same time\, work is also underway towards identifying potential vaccines. Join UBC experts from the Faculty of Medicine and Faculty of Pharmaceutical Sciences as they explain the process and timelines of developing and testing therapeutic drugs and vaccines for COVID-19\, and learn why a global approach is so important. \nThis is the fifth webinar in our COVID-19 series. View the previous webinars here. \nThis webinar is open to all. \nModerated by\nMary Lynn Young – Associate Professor\, UBC School of Journalism; Co-Founder\, The Conversation Canada \nFeaturing\nDr. Fawziah Lalji\, BSc’90\, PharmD’94 – Professor\, UBC Faculty of Pharmaceutical Sciences; Tong Louie Chair in Pharmaceutical Sciences \nDr. Srinivas Murthy\, MHSc’16 – Clinical Associate Professor\, UBC Department of Pediatrics; Infectious Disease Specialist and Investigator at BC Children’s Hospital
URL:https://scienceinvancouver.com/event/webinar-tackling-covid-19-global-collaborations-in-therapeutic-drug-trials-and-vaccine-development-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/COVID19-webinar-May-20.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T113000
DTEND;TZID=America/Vancouver:20200520T123000
DTSTAMP:20260407T213857
CREATED:20200514T195109Z
LAST-MODIFIED:20200514T195109Z
UID:27776-1589974200-1589977800@scienceinvancouver.com
SUMMARY:Webinar: Tackling COVID-19: Global Collaborations in Therapeutic Drug Trials and Vaccine Development
DESCRIPTION:It’s an unusual time in the world of medical and pharmaceutical research. The slow\, methodical work that is typically conducted out of view by researchers in labs around the world has been driven into the spotlight by a worldwide need for hope. The hope for effective treatments\, vaccines\, and a return to “normal” is coming from many different directions. The World Health Organization Solidarity Trial\, a multi-national collaboration\, is running clinical trials in an effort to determine which drugs are effective in treating the symptoms of COVID-19. At the same time\, work is also underway towards identifying potential vaccines. Join UBC experts from the Faculty of Medicine and Faculty of Pharmaceutical Sciences as they explain the process and timelines of developing and testing therapeutic drugs and vaccines for COVID-19\, and learn why a global approach is so important. \nThis is the fifth webinar in our COVID-19 series. View the previous webinars here. \nThis webinar is open to all. \nModerated by\nMary Lynn Young – Associate Professor\, UBC School of Journalism; Co-Founder\, The Conversation Canada \nFeaturing\nDr. Fawziah Lalji\, BSc’90\, PharmD’94 – Professor\, UBC Faculty of Pharmaceutical Sciences; Tong Louie Chair in Pharmaceutical Sciences \nDr. Srinivas Murthy\, MHSc’16 – Clinical Associate Professor\, UBC Department of Pediatrics; Infectious Disease Specialist and Investigator at BC Children’s Hospital
URL:https://scienceinvancouver.com/event/webinar-tackling-covid-19-global-collaborations-in-therapeutic-drug-trials-and-vaccine-development-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/COVID19-webinar-May-20.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T113000
DTEND;TZID=America/Vancouver:20200520T123000
DTSTAMP:20260407T213857
CREATED:20200514T195109Z
LAST-MODIFIED:20200514T195109Z
UID:30859-1589974200-1589977800@scienceinvancouver.com
SUMMARY:Webinar: Tackling COVID-19: Global Collaborations in Therapeutic Drug Trials and Vaccine Development
DESCRIPTION:It’s an unusual time in the world of medical and pharmaceutical research. The slow\, methodical work that is typically conducted out of view by researchers in labs around the world has been driven into the spotlight by a worldwide need for hope. The hope for effective treatments\, vaccines\, and a return to “normal” is coming from many different directions. The World Health Organization Solidarity Trial\, a multi-national collaboration\, is running clinical trials in an effort to determine which drugs are effective in treating the symptoms of COVID-19. At the same time\, work is also underway towards identifying potential vaccines. Join UBC experts from the Faculty of Medicine and Faculty of Pharmaceutical Sciences as they explain the process and timelines of developing and testing therapeutic drugs and vaccines for COVID-19\, and learn why a global approach is so important. \nThis is the fifth webinar in our COVID-19 series. View the previous webinars here. \nThis webinar is open to all. \nModerated by\nMary Lynn Young – Associate Professor\, UBC School of Journalism; Co-Founder\, The Conversation Canada \nFeaturing\nDr. Fawziah Lalji\, BSc’90\, PharmD’94 – Professor\, UBC Faculty of Pharmaceutical Sciences; Tong Louie Chair in Pharmaceutical Sciences \nDr. Srinivas Murthy\, MHSc’16 – Clinical Associate Professor\, UBC Department of Pediatrics; Infectious Disease Specialist and Investigator at BC Children’s Hospital
URL:https://scienceinvancouver.com/event/webinar-tackling-covid-19-global-collaborations-in-therapeutic-drug-trials-and-vaccine-development-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/COVID19-webinar-May-20.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200520T113000
DTEND;TZID=America/Vancouver:20200520T123000
DTSTAMP:20260407T213857
CREATED:20200514T195109Z
LAST-MODIFIED:20200514T195109Z
UID:32319-1589974200-1589977800@scienceinvancouver.com
SUMMARY:Webinar: Tackling COVID-19: Global Collaborations in Therapeutic Drug Trials and Vaccine Development
DESCRIPTION:It’s an unusual time in the world of medical and pharmaceutical research. The slow\, methodical work that is typically conducted out of view by researchers in labs around the world has been driven into the spotlight by a worldwide need for hope. The hope for effective treatments\, vaccines\, and a return to “normal” is coming from many different directions. The World Health Organization Solidarity Trial\, a multi-national collaboration\, is running clinical trials in an effort to determine which drugs are effective in treating the symptoms of COVID-19. At the same time\, work is also underway towards identifying potential vaccines. Join UBC experts from the Faculty of Medicine and Faculty of Pharmaceutical Sciences as they explain the process and timelines of developing and testing therapeutic drugs and vaccines for COVID-19\, and learn why a global approach is so important. \nThis is the fifth webinar in our COVID-19 series. View the previous webinars here. \nThis webinar is open to all. \nModerated by\nMary Lynn Young – Associate Professor\, UBC School of Journalism; Co-Founder\, The Conversation Canada \nFeaturing\nDr. Fawziah Lalji\, BSc’90\, PharmD’94 – Professor\, UBC Faculty of Pharmaceutical Sciences; Tong Louie Chair in Pharmaceutical Sciences \nDr. Srinivas Murthy\, MHSc’16 – Clinical Associate Professor\, UBC Department of Pediatrics; Infectious Disease Specialist and Investigator at BC Children’s Hospital
URL:https://scienceinvancouver.com/event/webinar-tackling-covid-19-global-collaborations-in-therapeutic-drug-trials-and-vaccine-development-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/05/COVID19-webinar-May-20.jpg
END:VEVENT
END:VCALENDAR